Increased IL-33 in serum or tumor tissue may correlate with poor prognosis in several types of cancers, while, on the contrary, IL-33 can also stimulate anti-tumor immune response and thus contributes to tumor cell elimination [10]. This evidence concerns the gene IL33 and cancer.